Remission InductionRemission, SpontaneousColitis, UlcerativeTreatment OutcomeMesalamineRecurrenceCrohn DiseaseAntirheumatic AgentsPrednisolonePulse Therapy, DrugTonsillectomyMethotrexateFollow-Up StudiesAnti-Inflammatory AgentsColitis, CollagenousArthritis, RheumatoidPrednisoneCytapheresisGastrointestinal AgentsNeoplasm, ResidualArthritis, JuvenileAntineoplastic Combined Chemotherapy ProtocolsLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaCyclophosphamidePrognosisDrug Therapy, CombinationLeukemia, LymphoidAminosalicylic AcidsSeverity of Illness IndexImmunosuppressive Agents6-MercaptopurineLeukemia, Promyelocytic, AcuteCombined Modality TherapyTime FactorsCytarabineTransplantation, AutologousAntibodies, MonoclonalDrug Administration ScheduleMaintenance ChemotherapyBone MarrowProspective StudiesWegener GranulomatosisSulfasalazineAdrenal Cortex HormonesGlucocorticoidsAntibodies, Monoclonal, Murine-DerivedAcute DiseaseDouble-Blind MethodVincristineInflammatory Bowel DiseasesRetrospective StudiesDisease-Free SurvivalOxidesBlood SedimentationSynovitisHematopoietic Stem Cell TransplantationLymphoma, Non-HodgkinDaunorubicinEnemaVasculitisGlomerulonephritis, IGAArsenicalsAntibodies, Monoclonal, HumanizedSurvival AnalysisAntineoplastic AgentsDisease ProgressionAnti-Inflammatory Agents, Non-SteroidalBone Marrow TransplantationLeukemia, MyeloidNephrotic SyndromeDrug ResistanceAdministration, OralAntigens, CD20Gene RearrangementOncogene Proteins, FusionSteroidsNeoplasm Recurrence, LocalImmunoglobulin GPolymerase Chain ReactionColonoscopyTransplantation, HomologousDoxorubicinTranslocation, GeneticThioguanineAsparaginaseAutoantibodiesC-Reactive ProteinBiological MarkersEtoposideTretinoinLeukemiaIdarubicinLongitudinal StudiesSalvage TherapySurvival RatePilot ProjectsHodgkin DiseaseLupus Erythematosus, SystemicCohort Studies